Skip to main content
Clinical Trials/IRCT20180624040228N1
IRCT20180624040228N1CompletedPhase 3

Study of the effect of synbiotic supplement on glycemic and lipid profile indices, inflammatory factors, oxidative stress condition and expression of related microRNAs in T2DM patients

Yazd University of Medical Sciences0 sites72 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
72

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
25 years to 65 years (—)
Sex
All

Inclusion Criteria

  • Men and women with type 2 diabetes (the minimum elapsed time of diagnosis is 3 months and diabetes treatment is started in person)
  • Age range 25 to 65 years
  • Glycosylated hemoglobin above 6.5% and below 8.5%
  • BMI is between 25 and 35

Exclusion Criteria

  • Using alternative therapies with hormone (Insulin, Corticosteroids) or vitamin supplements
  • Chronic kidney, liver, pulmonary diseases. chronic or acute inflammatory diseases (especially acute Pancreatic inflammation and Endocarditis)
  • Valvular disease of the heart. Irritable Bowel Syndrome. Allergic
  • Diabetes complications (Nephropathy, Cardiomyopathy, Retinopathy, Diabetic foot ulcers)
  • People with low immune system (Autoimmune)
  • Pregnancy, Lactation
  • Use of tobacco and alcohol
  • Probiotic consumption in the last three months
  • Follow the unusual diet up to 1month before the study

Investigators

Sponsor
Yazd University of Medical Sciences

Similar Trials